Protocolo de práctica asistencial: consejo genético en tumores de la mujer

  1. Cortegoso Mosquera, A. 1
  2. Álvarez Fernández, J. 1
  3. Palacios Ozores, P. 1
  4. Cebey López, V. 1
  5. López López, R. 1
  1. 1 Servicio de Oncología Médica y Grupo de Oncología Médica Traslacional, Hospital Clínico Universitario e Instituto de Investigación Sanitaria-CIBERONC, Santiago de Compostela, La Coruña, España
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Ano de publicación: 2021

Título do exemplar: Enfermedades oncológicas (IV)Melanoma, cáncer de mama y tumores ginecológicos

Serie: 13

Número: 27

Páxinas: 1538-1542

Tipo: Artigo

DOI: 10.1016/J.MED.2021.03.005 DIALNET GOOGLE SCHOLAR

Outras publicacións en: Medicine: Programa de Formación Médica Continuada Acreditado

Obxectivos de Desenvolvemento Sustentable

Resumo

About 2% of endometrial cancers, 7% of breast cancers and 15% of ovarian cancers are hereditary. In order to prevent cancer development and to set up the proper treatment, it is mandatory to identify those patients and their relatives. According with current scientific evidence and clinical practice guidelines, we propose an algorithm to facilitate the diagnosis of suspected inherited cancer and the appropriate referral of patients to hereditary cancer genetic counseling units (HCGCUs).

Referencias bibliográficas

  • Network NCC. Ovarian Cancer (version 1.2020)
  • National Comprehensive Cancer Network. Breast Cancer (version 6.2020)
  • Network. NCC. Uterine Neoplasm (version 2.2020). 2020.
  • González Santiago S, Ramón y Cajal T, Aguirre E, Alés Martínez JE, Andrés R, Balmaña J, et al. SEOM clinical guidelines in hereditary breast and ovarian cancer (2019). Clin Transl Oncol 2020;22(2):193-200.
  • Guillén Ponce C, Lastra E, Lorenzo-Lorenzo I, Martín Gómez T, Morales Chamorro R, Sánchez-Heras AB, et al. SEOM clinical guideline on hereditary colorectal cancer (2019). Clin Transl Oncol 2020;22(2):201-12.
  • Network NCC. Genetic/familiar high risk assessment: breast, ovarian, and pancreatic (version 1.2020). 2020.
  • Network NCC. Genetic/familial high risk assessment: Colorectal. 2020.
  • Rebbeck TR, Kauff ND, Domchek SM. Meta analysis of risk reduction estimates associated with risk reducing salpingo oophorectomy in BRCA1 or BRCA2 mutation carriers. JNCI J Natl Cancer Inst 2009;101(2):80-7.
  • Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. JNCI J Natl Cancer Inst 2013; 105(11):812-22.
Fonte de datos: Dialnet